Relay Therapeutics Ownership | Who Owns Relay Therapeutics?
Relay Therapeutics Ownership Summary
Relay Therapeutics is owned by 137.92% institutional investors, 1.69% insiders. Sb investment advisers (uk) is the largest institutional shareholder, holding 15.52% of RLAY shares. BB Biotech AG Ord is the top mutual fund, with 4.41% of its assets in Relay Therapeutics shares.
RLAY Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Relay Therapeutics | 137.92% | 1.69% | -39.61% |
| Sector | Healthcare Stocks | 244.59% | 12.11% | -156.70% |
| Industry | Biotech Stocks | 379.61% | 11.70% | -291.31% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Sb investment advisers (uk) | 27.90M | 15.52% | $522.10M |
| Fmr | 20.11M | 11.18% | $376.26M |
| Casdin capital | 16.04M | 8.92% | $300.02M |
| Blackrock funding, inc. /de | 15.29M | 8.50% | $286.04M |
| Blackrock | 10.54M | 7.94% | $68.74M |
| Perceptive advisors | 14.11M | 7.84% | $263.93M |
| Commodore capital lp | 12.00M | 6.67% | $224.52M |
| State street | 10.13M | 5.63% | $189.47M |
| Vanguard group | 9.69M | 5.62% | $81.99M |
| Vanguard capital management | 8.96M | 4.98% | $167.72M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Casdin capital | 16.04M | 15.02% | $300.02M |
| Commodore capital lp | 12.00M | 13.37% | $224.52M |
| Foresite capital management iv | 1.25M | 8.06% | $23.39M |
| Sb investment advisers (uk) | 27.90M | 6.81% | $522.10M |
| Nextech invest | 6.78M | 6.02% | $126.79M |
| Perceptive advisors | 14.11M | 3.96% | $263.93M |
| Kynam capital management, lp | 3.30M | 3.41% | $61.74M |
| Bioimpact capital | 2.42M | 2.76% | $45.20M |
| Nextech invest | 3.85M | 2.57% | $15.85M |
| Bellevue group | 6.19M | 2.44% | $115.74M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Fmr | 20.11M | 0.02% | 16.41M |
| Price t rowe associates inc /md/ | 7.71M | 0.01% | 5.78M |
| Perceptive advisors | 14.11M | 3.96% | 4.36M |
| Alliancebernstein | 4.10M | 0.01% | 3.95M |
| State street | 10.13M | 0.01% | 3.89M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Point72 asset management | - | - | -13.86M |
| Commodore capital lp | 12.00M | 13.37% | -5.00M |
| Braidwell lp | - | - | -3.50M |
| Balyasny asset management | 112.99K | 0.00% | -2.93M |
| Eventide asset management | - | - | -2.68M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Siren | 3.65M | 1.38% | 3.65M | $68.29M |
| Westfield capital management co lp | 3.34M | 0.20% | 3.34M | $62.56M |
| T. rowe price investment management | 1.92M | 0.02% | 1.92M | $35.84M |
| Polar capital | 1.79M | 0.08% | 1.79M | $33.47M |
| Sixth street partners management company | 1.50M | 0.00% | 1.50M | $28.08M |
Sold Out
| Holder | Change |
|---|---|
| Tfc financial management | -1.00 |
| Aster capital management (difc) | -10.00 |
| Capital performance advisors llp | -11.00 |
| Nelson, van denburg & campbell wealth management group | -18.00 |
| First command advisory services | -25.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | 266 | 7.69% | 248,047,004 | 35.08% | 137 | 1.32% | 168 | 16.67% | 63 | 16.67% |
| Mar 31, 2026 | 123 | -46.05% | 37,220,983 | -78.55% | 21 | 0.21% | 66 | -44.07% | 31 | -45.61% |
| Dec 31, 2025 | 150 | -26.11% | 57,894,103 | -65.17% | 33 | 0.36% | 73 | -15.12% | 39 | -38.10% |
| Sep 30, 2025 | 192 | -3.52% | 164,241,668 | -1.23% | 95 | 1.02% | 79 | -25.47% | 63 | 26.00% |
| Jun 30, 2025 | 203 | -3.33% | 170,787,021 | 4.95% | 99 | 1.08% | 106 | -3.64% | 54 | -5.26% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| BB Biotech AG Ord | 7.38M | 4.41% | - |
| Vanguard Morn Total Stk Mkt Idx Investor | 6.80M | 3.12% | -35.27K |
| Vanguard Total Stock Mkt Idx Inv | 6.80M | 3.12% | -35.27K |
| Vanguard MStar Total Stk Mkt Idx Invest | 6.83M | 3.11% | 24.24K |
| Vanguard US Total Market Shares ETF | 4.89M | 2.88% | 904.00K |
| State Street® SPDR® S&P® Biotech ETF | 6.19M | 2.82% | 14.21K |
| iShares Russell 2000 ETF | 4.12M | 1.88% | -73.25K |
| Eventide Healthcare & Life Sciences I | 2.68M | 1.56% | - |
| JPMorgan Small Cap Growth A | 2.20M | 1.29% | 32.86K |
| SPDR® S&P Biotech ETF | 2.22M | 1.29% | 4.95K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Sep 08, 2026 | Bergstrom Donald A | President, R&D | Sell | $161.81K |
| Sep 08, 2026 | Catinazzo Thomas | Chief Financial Officer | Sell | $335.56K |
| Sep 08, 2026 | Patel Sanjiv | President and CEO | Sell | $912.89K |
| Aug 26, 2026 | Rahmer Peter | See remarks | Sell | $90.30K |
| Aug 25, 2026 | SVF Pauling (Cayman) Ltd | - | Sell | $116.40M |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q3 | - | 13 |
| 2026 Q2 | - | 10 |
| 2026 Q1 | - | 8 |
| 2025 Q4 | - | 5 |
| 2025 Q3 | - | 10 |
RLAY Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools